You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 13, 2024

CLINICAL TRIALS PROFILE FOR CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Children's Cetirizine Hydrochloride Allergy

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00253058 ↗ Study Of Perennial Allergic Rhinitis In Pediatrics Completed GlaxoSmithKline Phase 3 2005-07-01 To verify of cetirizine dry syrup to ketotifen dry syrup in the change of total nasal symptom score (TNSS) over the total treatment period from the score of the baseline assessment period
NCT00257569 ↗ Study Of Atopic Dermatitis In Pediatrics Completed GlaxoSmithKline Phase 3 2005-08-01 To verify of cetirizine dry syrup to ketotifen dry syrup in the change in the severity of pruritus of the treatment period.
NCT00257582 ↗ Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics Completed GlaxoSmithKline Phase 3 2005-08-01 To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.
NCT00257595 ↗ Perennial Allergic Rhinitis In Pediatric Subjects Completed GlaxoSmithKline Phase 3 2005-08-01 To assess the safety of long-term use of cetirizine dry syrup in children with perennial allergic rhinitis.
NCT00488176 ↗ Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status Medical University of Lodz Phase 4 2007-04-01 The aim of this study is to compare the effect of montelukast and cetirizine on allergic inflammation measured by exhaled nitric oxide concentration in children with seasonal allergic rhinitis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Children's Cetirizine Hydrochloride Allergy

Condition Name

Condition Name for Children's Cetirizine Hydrochloride Allergy
Intervention Trials
Allergic Rhinitis 4
Rhinitis, Allergic, Perennial 4
Seasonal Allergic Rhinitis 1
Anaphylaxis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Children's Cetirizine Hydrochloride Allergy
Intervention Trials
Rhinitis, Allergic 9
Rhinitis 9
Rhinitis, Allergic, Perennial 4
Rhinitis, Allergic, Seasonal 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Children's Cetirizine Hydrochloride Allergy

Trials by Country

Trials by Country for Children's Cetirizine Hydrochloride Allergy
Location Trials
Italy 2
Japan 1
Poland 1
Qatar 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Children's Cetirizine Hydrochloride Allergy

Clinical Trial Phase

Clinical Trial Phase for Children's Cetirizine Hydrochloride Allergy
Clinical Trial Phase Trials
Phase 4 3
Phase 3 8
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Children's Cetirizine Hydrochloride Allergy
Clinical Trial Phase Trials
Completed 10
Unknown status 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Children's Cetirizine Hydrochloride Allergy

Sponsor Name

Sponsor Name for Children's Cetirizine Hydrochloride Allergy
Sponsor Trials
GlaxoSmithKline 5
Merck Sharp & Dohme Corp. 2
Johnson & Johnson Consumer and Personal Products Worldwide 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Children's Cetirizine Hydrochloride Allergy
Sponsor Trials
Industry 11
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.